{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:26:19Z","timestamp":1787498779739,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003009","name":"Science and Technology Development Fund","doi-asserted-by":"publisher","award":["48275"],"award-info":[{"award-number":["48275"]}],"id":[{"id":"10.13039\/501100003009","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bioorg.2026.109695","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:42:02Z","timestamp":1772005322000},"page":"109695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Discovery of 4-[2.2]paracyclophanylthiazole derivatives as topoisomerase ll\/malic enzyme 1 inhibitors modulating autophagy\/apoptosis pathways in breast cancer therapy"],"prefix":"10.1016","volume":"174","author":[{"given":"Lamiaa E.","family":"Abd El-Haleem","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf A.","family":"Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa H.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam T.","family":"Fahmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Fuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek M.","family":"Okda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marwa E.","family":"Abdelaziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman J.","family":"El-Agroudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2026.109695_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2024.103119","article-title":"Can exercise as a complementary technique manage inflammatory markers in women with breast cancer who are overweight and obese? A systematic review and meta-analysis","volume":"88","author":"Tan","year":"2025","journal-title":"Complement. Ther. Med."},{"key":"10.1016\/j.bioorg.2026.109695_bb0010","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat. Med."},{"key":"10.1016\/j.bioorg.2026.109695_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.116061","article-title":"Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment","volume":"265","author":"Guo","year":"2024","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0020","article-title":"Repurposing proteasome inhibitors for improved treatment of triple-negative breast cancer","volume":"101","author":"Larsson","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.bioorg.2026.109695_bb0025","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/s41598-024-81294-1","article-title":"New thiazole derivative as a potential anticancer and topoisomerase II inhibitor","volume":"15","author":"Shosha","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109695_bb0030","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1080\/14756366.2022.2136172","article-title":"Design, synthesis, and biological evaluation of novel ciprofloxacin derivatives as potential anticancer agents targeting topoisomerase II enzyme","volume":"38","author":"Swedan","year":"2023","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108672","article-title":"Discovery of novel thiazolopyrimidine derivatives targeting topoisomerase II: design, synthesis, antiproliferative evaluation, molecular docking and apoptosis inducing activity","volume":"163","author":"Ewieda","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0040","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.bmc.2006.12.012","article-title":"Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones","volume":"154","author":"Rhee","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103273","article-title":"Malic enzymes in cancer: regulatory mechanisms, functions, and therapeutic implications","volume":"75","author":"Wang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/cimb47020083","article-title":"Significance of malic enzyme 1 in Cancer: a review","volume":"47","author":"Fujiwara-Tani","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/jcmm.18163","article-title":"Overexpression of malic enzyme is involved in breast cancer growth and is correlated with poor prognosis","volume":"28","author":"Hu","year":"2024","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bioorg.2026.109695_bb0060","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bmcl.2005.10.065","article-title":"In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scaffold-based novel malic enzyme inhibitors","volume":"16","author":"Zhang","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2026.109695_bb0065","doi-asserted-by":"crossref","first-page":"1506426","DOI":"10.3389\/fimmu.2024.1506426","article-title":"Beclin-1: a therapeutic target at the intersection of autophagy, immunotherapy, and cancer treatment","volume":"15","author":"Cao","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0070","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2020478118","article-title":"Tumor-suppressor function of Beclin 1 in breast cancer cells requires E-cadherin","volume":"118","author":"Wijshake","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2026.109695_bb0075","article-title":"Autophagosome marker, LC 3, is released extracellularly via several distinct pathways","author":"Saito","year":"2025","journal-title":"FEBS Open Bio."},{"key":"10.1016\/j.bioorg.2026.109695_bb0080","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s43556-025-00385-1","article-title":"PARPs and PARP inhibitors: molecular mechanisms and clinical applications","volume":"6","author":"Wang","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.bioorg.2026.109695_bb0085","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s11658-023-00434-z","article-title":"p20BAP31 induces cell apoptosis via both AIF caspase-independent and the ROS\/JNK mitochondrial pathway in colorectal cancer","volume":"8","author":"Jiang","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.bioorg.2026.109695_bb0090","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/164915b0","article-title":"Preparation and structure of di-p-xylylene","volume":"164","author":"Brown","year":"1949","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2026.109695_bb0095","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1021\/ja01156a059","article-title":"Macro rings. I. Preparation and spectra of the paracyclophanes","volume":"73","author":"Cram","year":"1951","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109695_bb0100","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/anie.201904863","article-title":"Regioselective functionalization of [2.2] paracyclophanes: recent synthetic progress and perspectives","volume":"59","author":"Hassan","year":"2020","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bioorg.2026.109695_bb0105","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1021\/ar50042a003","article-title":"Cyclophane chemistry: bent and battered benzene rings","volume":"46","author":"Cram","year":"1971","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.bioorg.2026.109695_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/marc.202500145","article-title":"[2.2]Paracyclophane materials \u2013 status and perspectives","volume":"46","author":"Tappert","year":"2025","journal-title":"Macromol. Rapid Commun."},{"key":"10.1016\/j.bioorg.2026.109695_bb0115","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1021\/jo047864d","article-title":"A computational study of [2.2]cyclophanes","volume":"70","author":"Caramori","year":"2005","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0120","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1021\/jp111523u","article-title":"DFT study of [2.2]-,[3.3]-, and [4.4]paracyclophanes: strain energy, conformations, and rotational barriers","volume":"115","author":"Bachrach","year":"2011","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.bioorg.2026.109695_bb0125","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1021\/acs.orglett.0c02463","article-title":"2-(Dimesitylboryl) phenyl-substituted [2.2] paracyclophanes featuring intense and sign-invertible circularly polarized luminescence","volume":"23","author":"Zhang","year":"2020","journal-title":"Org. Lett."},{"key":"10.1016\/j.bioorg.2026.109695_bb0130","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1039\/C5CC00694E","article-title":"Planar-chiral building blocks for metal\u2013organic frameworks","volume":"51","author":"Cakici","year":"2015","journal-title":"Chem. Commun."},{"key":"10.1016\/j.bioorg.2026.109695_bb0135","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.3390\/molecules25235569","article-title":"Design, synthesis, and molecular docking of paracyclophanyl-thiazole hybrids as novel CDK1 inhibitors and apoptosis inducing anti-melanoma agents","volume":"25","author":"Aly","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109695_bb0140","doi-asserted-by":"crossref","first-page":"3089","DOI":"10.3390\/molecules25133089","article-title":"New paracyclophanylthiazoles with anti-leukemia activity: design, synthesis, molecular docking, and mechanistic studies","volume":"25","author":"Aly","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.109695_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2024.137510","article-title":"Thiazole moiety: a promising scaffold for anticancer drug discovery","volume":"1303","author":"Kassem","year":"2024","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109695_bb0150","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00706-024-03259-4","article-title":"New thiazolo-quinolone hybrids as EGFR and\/or PI3K inhibitors and as apoptosis inducers via modulating Bax\/Bcl-2\/p53 cascade","volume":"155","author":"Mohamed","year":"2024","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.arabjc.2023.104612","article-title":"Design, synthesis, docking and mechanistic studies of new thiazolyl\/thiazolidinylpyrimidine-2,4-dione antiproliferative agents","volume":"16","author":"Aly","year":"2023","journal-title":"Arab. J. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0160","doi-asserted-by":"crossref","first-page":"946","DOI":"10.3390\/ph16070946","article-title":"Novel thiazolidine-2, 4-dione-trimethoxybenzene-thiazole hybrids as human topoisomerases inhibitors","volume":"16","author":"Sinicropi","year":"2023","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.bioorg.2026.109695_bb0165","doi-asserted-by":"crossref","first-page":"2311818","DOI":"10.1080\/14756366.2024.2311818","article-title":"New imidazole-2-thiones linked to acenaphythylenone as dual DNA intercalators and topoisomerase II inhibitors: structural optimization, docking, and apoptosis studies","volume":"39","author":"Mohamed","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0170","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1021\/ja208503y","article-title":"Strained cyclophane macrocycles: impact of progressive ring size reduction on synthesis and structure","volume":"134","author":"Bogdan","year":"2012","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109695_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2024.104115","article-title":"Targeting cancer using scaffold-hopping approaches: illuminating SAR to improve drug design","volume":"29","author":"Shivani","year":"2024","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.109695_bb0180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s10876-021-01995-9","article-title":"Preparation of novel nickel oxide@ glutamic\/thiosemicarbazide nanoparticles: implications for cytotoxic and anti-cancer studies in MCF-7 breast cancer cells","volume":"33","author":"Abbaszadeh","year":"2022","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.bioorg.2026.109695_bb0185","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s10876-018-1424-0","article-title":"Functionalization of Ag nanoparticles by glutamic acid and conjugation of Ag@ Glu by thiosemicarbazide enhances the apoptosis of human breast cancer MCF-7 cells","volume":"29","author":"Sadat Shandiz","year":"2018","journal-title":"J. Clust. Sci."},{"key":"10.1016\/j.bioorg.2026.109695_bb0190","doi-asserted-by":"crossref","first-page":"33383","DOI":"10.1021\/acsomega.5c03358","article-title":"Synthesis, characterization, anticancer, antioxidant, and in silico evaluation of semicarbazides and thiosemicarbazides","volume":"10","author":"Shahzadi","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.bioorg.2026.109695_bb0195","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.molstruc.2018.10.036","article-title":"Tridentate and bidentate copper complexes of [2.2]paracyclophanyl-substituted thiosemicarbazones, thiocarbazones, hydrazones and thioureas","volume":"1178","author":"Aly","year":"2019","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2026.109695_bb0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106610","article-title":"Design, synthesis and molecular docking study of new pyrimidine-based hydrazones with selective anti-proliferative activity against MCF-7 and MDA-MB-231 human breast cancer cell lines","volume":"138","author":"Badawi","year":"2023","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.bioorg.2026.109695_bb0210","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.fitote.2008.06.007","article-title":"Cytotoxic activity screening of some indigenous Thai plants","volume":"79","author":"Prayong","year":"2008","journal-title":"Fitoterapia"},{"key":"10.1016\/j.bioorg.2026.109695_bb0215","doi-asserted-by":"crossref","first-page":"937","DOI":"10.3390\/pharmaceutics16070937","article-title":"Design and optimization of sesamol nanosuspensions to potentiate the anti-tumor activity of epirubicin against Ehrlich solid carcinoma-bearing mice","volume":"16","author":"Elzanaty","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bioorg.2026.109695_bb0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2025.108564","article-title":"Discovery of new pyridine-O-propargyl\/1,2,3-triazole hybrids as competitive and non-competitive PIM-1 kinase inhibitors with apoptosis induction and caspase 3\/7 activation capabilities","volume":"162","author":"Abdelaziz","year":"2025","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0225","doi-asserted-by":"crossref","first-page":"2304044","DOI":"10.1080\/14756366.2024.2304044","article-title":"Imparting aromaticity to 2-pyridone derivatives by O-alkylation resulted in new competitive and non-competitive PIM-1 kinase inhibitors with caspase-activated apoptosis","volume":"39","author":"Abdelaziz","year":"2024","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0230","article-title":"Flow cytometry-based quantitative analysis of cellular protein expression in apoptosis subpopulations: a protocol","volume":"1013","author":"Alshehade","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.bioorg.2026.109695_bb0235","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/s41421-025-00791-3","article-title":"Caspases: structural and molecular mechanisms and functions in cell death, innate immunity, and disease","volume":"11","author":"Nadendla","year":"2025","journal-title":"Cell Discov."},{"key":"10.1016\/j.bioorg.2026.109695_bb0240","first-page":"354","article-title":"A review on quinoline hydrazone derivatives as a new class of potent antitubercular and anticancer agents","volume":"6","author":"Mandewale","year":"2017","journal-title":"Beni Suef Univ. J. Basic Appl. Sci."},{"key":"10.1016\/j.bioorg.2026.109695_bb0245","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1021\/ci800293n","article-title":"Validation of molecular docking programs for virtual screening against dihydropteroate synthase","volume":"49","author":"Hevener","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.bioorg.2026.109695_bb0250","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1021\/acs.biochem.2c00123","article-title":"Discovery and characterization of a novel allosteric small-molecule inhibitor of NADP+-dependent malic enzyme 1","volume":"61","author":"Yoshida","year":"2022","journal-title":"Biochemistry"},{"key":"10.1016\/j.bioorg.2026.109695_bb0255","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","article-title":"The role of ligand efficiency metrics in drug discovery","volume":"13","author":"Hopkins","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioorg.2026.109695_bb0260","doi-asserted-by":"crossref","first-page":"42717","DOI":"10.1038\/srep42717","article-title":"Swissadme: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules","volume":"7","author":"Daina","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2026.109695_bb0265","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/cmdc.201600182","article-title":"A boiled-egg to predict gastrointestinal absorption and brain penetration of small molecules","volume":"11","author":"Daina","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bioorg.2026.109695_bb0270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.drudis.2007.12.010","article-title":"The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (adme-tox)","volume":"13","author":"Szakacs","year":"2008","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.bioorg.2026.109695_bb0275","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/jccs.200400023","article-title":"Synthesis, reactions and antimicrobial activity of some new indolyl-1,3,4-oxadiazole, triazole and pyrazole derivatives","volume":"51","author":"Farghaly","year":"2004","journal-title":"J. Chin. Chem. Soc."},{"key":"10.1016\/j.bioorg.2026.109695_bb0280","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1517\/17425255.2014.876006","article-title":"The role of drug metabolizing enzymes in clearance","volume":"10","author":"Di","year":"2014","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1081\/DMR-120001387","article-title":"Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes","volume":"34","author":"Hollenberg","year":"2002","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.bioorg.2026.109695_bb0290","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1177\/0091270007312153","article-title":"New era in drug interaction evaluation: Us Food and Drug Administration update on cyp enzymes, transporters, and the guidance process","volume":"48","author":"Huang","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0295","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0300","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0305","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1107\/S0021889808042726","article-title":"OLEX2: a complete structure solution, refinement and analysis program","volume":"42","author":"Dolomanov","year":"2009","journal-title":"J. Appl. Cryst."},{"key":"10.1016\/j.bioorg.2026.109695_bb0310","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT - integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., A"},{"key":"10.1016\/j.bioorg.2026.109695_bb0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr., C"},{"key":"10.1016\/j.bioorg.2026.109695_bb0320","series-title":"Faculty of Medicine, Alexandria University, member of ICLAS, FWO: 00018699, sn: 0307502 (7\/9\/2025)","author":"Ethics Committee","year":"2026"},{"key":"10.1016\/j.bioorg.2026.109695_bb0325","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ab.2017.05.003","article-title":"Quantification of autophagy flux using LC3 ELISA","volume":"530","author":"Oh","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0330","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1080\/14756366.2018.1564046","article-title":"Novel pyrazolo[3,4-d]pyrimidines: design, synthesis, anticancer activity, dual EGFR\/ErbB2 receptor tyrosine kinases inhibitory activity, effects on cell cycle profile and caspase-3-mediated apoptosis","volume":"34","author":"Maher","year":"2019","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0335","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.tcb.2016.07.002","article-title":"Physiological and pharmacological control of BAK, BAX, and beyond","volume":"26","author":"Luna-Vargas","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bioorg.2026.109695_bb0340","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ab.2015.10.014","article-title":"An enzyme-linked immunosorbent assay-based system for determining the physiological level of poly(ADP-ribose) in cultured cells","volume":"494","author":"Ida","year":"2016","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.bioorg.2026.109695_bb0345","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0092-8674(03)00521-X","article-title":"Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes","volume":"114","author":"Micheau","year":"2003","journal-title":"Cell"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826002312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T08:48:10Z","timestamp":1774860490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826002312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":69,"alternative-id":["S0045206826002312"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109695","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of 4-[2.2]paracyclophanylthiazole derivatives as topoisomerase ll\/malic enzyme 1 inhibitors modulating autophagy\/apoptosis pathways in breast cancer therapy","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.109695","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109695"}}